TORONTO, Sept. 4, 2020 /CNW/ - GMP Capital Inc. ("GMP" or the "Company") (TSX: GMP) today acknowledged that it has received notice that a dissident shareholder intends to propose an alternative slate of nominees for election to the Company's Board of Directors.
GMP advises shareholders not to take any action at this time and to carefully read the Company's Management Information Circular, which is scheduled to be filed next week. The Circular will provide shareholders with more information about the Board election and about a proposed transaction involving Richardson GMP Limited that was announced on August 13, 2020. The Circular will explain why the Board supports the transaction and why the Board disagrees with the dissident, who has expressed opposition to the transaction.
As previously disclosed, GMP believes the transaction will best position the Company to capitalize on the compelling opportunities in the wealth management industry, which offers the greatest potential for long-term value creation for its shareholders.
GMP believes the transaction is in the best interest of the Company and all shareholders. The transaction was recommended by a special committee of independent directors of GMP, approved by the GMP Board, approved by the Richardson GMP Board (including the two Richardson GMP investment advisor representatives on the Board) and has already received support from advisors representing approximately 97% of Richardson GMP's assets under administration. RBC Capital Markets has also provided an opinion to GMP's Board that the transaction is fair, from a financial point of view, to the Company.
The election of directors is scheduled to take place at an annual and special meeting on October 6, 2020. A vote on the transaction is scheduled for the same meeting. GMP reiterates that the transaction should be approved based on its merits.
Shareholders with questions may contact the Company's strategic shareholder advisor and proxy solicitation agent, Kingsdale Advisors, at 1-866-879-7644 toll free in North America, or call collect outside North America at 1-416-867-2272 or by email at [email protected].
FORWARD-LOOKING INFORMATION
This press release contains "forward-looking information" as defined under applicable Canadian securities laws. This information includes, but is not limited to, statements concerning our objectives, our strategies to achieve those objectives, as well as statements made with respect to management's beliefs, plans, estimates, projections and intentions, and similar statements concerning anticipated future events, results, circumstances, performance or expectations that are not historical facts. Forward-looking information generally can be identified by the use of forward-looking terminology such as "outlook", "objective", "may", "will", "expect", "intend", "estimate", "anticipate", "believe", "should", "plans" or "continue", or similar expressions suggesting future outcomes or events. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement.
The forward-looking statements included in this press release, including statements regarding the RGMP Transaction, the nature of GMP's growth strategy going forward and execution of any of its potential plans, are not guarantees of future results and involve numerous risks and uncertainties that may cause actual results to differ materially from the potential results discussed in the forward-looking statements. In respect of the forward-looking statements and information concerning the consolidation of 100% of ownership in Richardson GMP, and the Company's strategy going forward, management has provided same based on reliance on certain assumptions it considers reasonable at this time including the timing of the completion of any transaction involving Richardson GMP and that any conditions precedent can be satisfied. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release.
Risks and uncertainties related to the RGMP Transaction include, but are not limited to: failure of GMP and RFGL to obtain the required shareholders and regulatory approvals for, or satisfy other conditions to effect, the RGMP Transaction; the risk that the RGMP Transaction may involve unexpected costs, liabilities or delays; the risk that, prior to or as a result of the completion of the RGMP Transaction, the business of GMP and/or Richardson GMP may experience significant disruptions, including loss of clients or employees due to transaction related uncertainty, industry conditions or other factors; risks relating to employee retention; the risk that legal proceedings may be instituted against GMP or Richardson GMP; and risks related to the diversion of management's attention from GMP's ongoing business operations. For a description of additional risks that could cause our actual results to materially differ from our current expectations, see the "Risk Management" and "Risk Factors" sections of GMP's most recent Annual and Interim MD&A and the "Risk Factors" section in the Company's AIF. For additional information on the risk factors related to the RGMP Transaction, see "The Sale Transaction – Reasons for the Sale Transaction" and "The Sale Transaction – Risk Factors" in GMP's Notice of Special Meeting and Management Information Circular dated July 8, 2019 (the "July 2019 Circular"). Material assumptions and factors underlying the forward-looking information in this press release include, but are not limited to, those set out in "Business Environment – Outlook" in GMP's most recent Annual and Interim MD&A. GMP's most recent Annual and Interim MD&A and July 2019 Circular are filed under the Corporation's profile on SEDAR at www.sedar.com.
Although forward-looking information contained in this press release is provided based on management's reliance on certain assumptions it considers reasonable, there can be no assurance that such expectations will prove to be correct. Certain statements included in this press release may be considered a "financial outlook" for purposes of applicable Canadian securities laws, and as such, the financial outlook may not be appropriate for purposes other than this press release. Readers should not place undue reliance on the forward-looking statements and information contained in this press release. When relying on forward-looking statements to make decisions, readers should carefully consider the foregoing factors, the list of which is not exhaustive.
The forward-looking information contained in this press release is made as of the date of this press release, and should not be relied upon as representing GMP's views as of any date subsequent to the date of this press release. Except as required by applicable law, Management and the Board undertake no obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
ABOUT GMP CAPITAL INC.
GMP currently operates through two business segments: Operations Clearing and Wealth Management; and a corporate segment. Operations Clearing provides carrying broker services to Richardson GMP and other third parties, including trade execution, clearing, settlement, custody, and certain other middle- and back-office services, and other expenses associated with providing such services. Wealth Management consists of GMP's non-controlling ownership interest in Richardson GMP. Richardson GMP, one of Canada's largest independent wealth management firms, is focused on providing exclusive and comprehensive wealth management and investment services delivered by an experienced team of investment professionals. GMP is listed on the Toronto Stock Exchange under the symbol "GMP". For further information, please visit our corporate website at gmpcapital.com.
SOURCE GMP Capital Inc.
![](https://rt.newswire.ca/rt.gif?NewsItemId=C7652&Transmission_Id=202009041643CANADANWCANADAPR_C7652&DateId=20200904)
GMP Capital Inc., Rocco Colella, Director, Investor Relations, 145 King Street West, Suite 200, Toronto, Ontario M5H 1J8, Tel: (416) 941-0894; Fax: (416) 943-6175, [email protected] or [email protected]; Media contact: Longview Communications and Public Affairs, Boyd Erman (416) 523-5885, [email protected]; Alan Bayless (604) 694-6035, [email protected]
Share this article